Cargando…
Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990–2011
PURPOSE: Distant relapse metastatic breast cancer (rMBC) incidence and survival are vital measures of breast cancer diagnosis and treatment progress over time. METHODS: We conducted a retrospective cohort study of stage I–III invasive breast cancer, 1990–2011, follow-up through 2016 [N = 8292, rMBC ...
Autores principales: | Malmgren, Judith, Hurlbert, Marc, Atwood, Mary, Kaplan, Henry G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422972/ https://www.ncbi.nlm.nih.gov/pubmed/30560462 http://dx.doi.org/10.1007/s10549-018-05090-y |
Ejemplares similares
-
Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010
por: Malmgren, Judith A., et al.
Publicado: (2017) -
Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
por: Kaplan, Henry G., et al.
Publicado: (2022) -
Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011
por: Malmgren, Judith A., et al.
Publicado: (2019) -
Breast cancer distant recurrence lead time interval by detection method in an institutional cohort
por: Kaplan, Henry G., et al.
Publicado: (2020) -
Increased incidence of myelodysplastic syndrome and acute myeloid leukemia following breast cancer treatment with radiation alone or combined with chemotherapy: a registry cohort analysis 1990-2005
por: Kaplan, Henry G, et al.
Publicado: (2011)